These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use. Spisek R; Bretaudeau L; Barbieux I; Meflah K; Gregoire M Cancer Immunol Immunother; 2001 Oct; 50(8):417-27. PubMed ID: 11726136 [TBL] [Abstract][Full Text] [Related]
4. Immunostimulatory properties of human dendritic cells generated using IFN-beta associated either with IL-3 or GM-CSF. Mazouz N; Detournay O; Buelens C; Renneson J; Trakatelli M; Lambermont M; Goldman M; Toungouz M Cancer Immunol Immunother; 2005 Oct; 54(10):1010-7. PubMed ID: 15864589 [TBL] [Abstract][Full Text] [Related]
5. Transient exposure of dendritic cells to maturation stimuli is sufficient to induce complete phenotypic maturation while preserving their capacity to respond to subsequent restimulation. Spisek R; Bougras G; Ebstein F; Masse D; Meflah K; McIlroy D; Gregoire M Cancer Immunol Immunother; 2003 Jul; 52(7):445-54. PubMed ID: 12700941 [TBL] [Abstract][Full Text] [Related]
6. Prostate cancer therapy using immune checkpoint molecules to target recombinant dendritic cells. Choi SY; Kim Y; Lim B; Wee CB; Chang IH; Kim CS Investig Clin Urol; 2024 May; 65(3):300-310. PubMed ID: 38714521 [TBL] [Abstract][Full Text] [Related]
7. Amplifying Immune Responses: Microparticulate Vaccine Approach Against Breast Cancer. Ubowski MM; VanSice R; Marriott M; Yacobucci MJ; Chablani L Breast Cancer (Dove Med Press); 2024; 16():149-162. PubMed ID: 38562650 [TBL] [Abstract][Full Text] [Related]
8. Current status of vaccine immunotherapy for gastrointestinal cancers. Suzuki N; Shindo Y; Nakajima M; Tsunedomi R; Nagano H Surg Today; 2023 Dec; ():. PubMed ID: 38043066 [TBL] [Abstract][Full Text] [Related]
9. Vaccine adjuvants: mechanisms and platforms. Zhao T; Cai Y; Jiang Y; He X; Wei Y; Yu Y; Tian X Signal Transduct Target Ther; 2023 Jul; 8(1):283. PubMed ID: 37468460 [TBL] [Abstract][Full Text] [Related]
10. Single-cell analysis of myeloid cells in HPV Jimenez DG; Altunbulakli C; Swoboda S; Sobti A; Askmyr D; Ali A; Greiff L; Lindstedt M Front Immunol; 2022; 13():1087843. PubMed ID: 36741389 [TBL] [Abstract][Full Text] [Related]
11. Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy. Chan Wah Hak CML; Rullan A; Patin EC; Pedersen M; Melcher AA; Harrington KJ Front Oncol; 2022; 12():971959. PubMed ID: 36106115 [TBL] [Abstract][Full Text] [Related]
13. Cytosolic delivery of the immunological adjuvant Poly I:C and cytotoxic drug crystals Du X; Hou Y; Huang J; Pang Y; Ruan C; Wu W; Xu C; Zhang H; Yin L; He W Acta Pharm Sin B; 2021 Oct; 11(10):3272-3285. PubMed ID: 34729315 [TBL] [Abstract][Full Text] [Related]
14. Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer. Sutherland SIM; Ju X; Horvath LG; Clark GJ Front Immunol; 2021; 12():641307. PubMed ID: 33854509 [TBL] [Abstract][Full Text] [Related]
15. Trial watch: TLR3 agonists in cancer therapy. Le Naour J; Galluzzi L; Zitvogel L; Kroemer G; Vacchelli E Oncoimmunology; 2020 Jun; 9(1):1771143. PubMed ID: 32934877 [TBL] [Abstract][Full Text] [Related]
18. In vivo cancer vaccination: Which dendritic cells to target and how? Chiang CL; Kandalaft LE Cancer Treat Rev; 2018 Dec; 71():88-101. PubMed ID: 30390423 [TBL] [Abstract][Full Text] [Related]
20. Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs. Francica JR; Zak DE; Linde C; Siena E; Johnson C; Juraska M; Yates NL; Gunn B; De Gregorio E; Flynn BJ; Valiante NM; Malyala P; Barnett SW; Sarkar P; Singh M; Jain S; Ackerman M; Alam M; Ferrari G; Salazar A; Tomaras GD; O'Hagan DT; Aderem A; Alter G; Seder RA Blood Adv; 2017 Nov; 1(25):2329-2342. PubMed ID: 29296883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]